Heat_NN
shock_NN
induces_VBZ
HIV-1_NN
replication_NN
in_IN
chronically_RB
infected_VBN
promyelocyte_JJ
cell_NN
line_NN
OM10_NN
.1_CD
._.

A_DT
long_JJ
period_NN
of_IN
clinical_JJ
latency_NN
before_IN
development_NN
of_IN
symptoms_NNS
is_VBZ
characteristic_JJ
of_IN
human_JJ
immunodeficiency_NN
virus_NN
type_NN
1_CD
-LRB-_-LRB-
HIV-1_NN
-RRB-_-RRB-
infection_NN
._.

OM10_NN
.1_CD
,_,
a_DT
promyelocyte_JJ
cell_NN
line_NN
latently_RB
infected_VBN
with_IN
HIV-1_NN
,_,
has_VBZ
been_VBN
developed_VBN
as_IN
a_DT
model_NN
for_IN
studying_VBG
the_DT
mechanism_NN
of_IN
viral_JJ
latency_NN
and_CC
the_DT
activation_NN
of_IN
virus_NN
expression_NN
._.

We_PRP
found_VBD
that_IN
this_DT
latently_RB
infected_VBN
cell_NN
line_NN
with_IN
heat_NN
shock_NN
at_IN
42_CD
degrees_NNS
C_NN
for_IN
2_CD
h_NN
resulted_VBD
in_IN
a_DT
high_JJ
level_NN
of_IN
HIV-1_NN
production_NN
without_IN
addition_NN
of_IN
any_DT
cytokines_NNS
._.

The_DT
mechanism_NN
of_IN
activation_NN
was_VBD
analyzed_VBN
by_IN
using_VBG
anti-TNF-alpha_JJ
antibody_NN
and_CC
various_JJ
inhibitors_NNS
._.

Although_IN
the_DT
TNF-alpha_NN
level_NN
in_IN
culture_NN
supernatants_NNS
was_VBD
below_IN
the_DT
sensitivity_NN
of_IN
an_DT
ELISA_NN
assay_NN
system_NN
,_,
addition_NN
of_IN
anti-TNF-alpha_JJ
antibody_NN
in_IN
culture_NN
medium_NN
could_MD
partially_RB
suppress_VB
the_DT
heat_NN
shock_NN
induced_VBD
HIV-1_NN
production_NN
._.

Staurosporine_NN
-LRB-_-LRB-
PKC_NN
inhibitor_NN
-RRB-_-RRB-
,_,
pentoxifylline_NN
-LRB-_-LRB-
NF-kappa_NN
B_NN
inhibitor_NN
-RRB-_-RRB-
,_,
and_CC
Ro5-3335_NN
-LRB-_-LRB-
HIV-1_NN
Tat_NN
inhibitor_NN
-RRB-_-RRB-
also_RB
inhibited_VBD
significantly_RB
the_DT
heat_NN
shock_NN
induced_VBD
virus_NN
activation_NN
._.

In_IN
particular_JJ
,_,
staurosporine_NN
achieved_VBD
approximately_RB
90_CD
%_NN
inhibition_NN
of_IN
the_DT
HIV-1_NN
antigen_NN
expression_NN
in_IN
heat_NN
shock-treated_JJ
OM10_NN
.1_CD
at_IN
a_DT
non-toxic_JJ
concentration_NN
._.

Although_IN
the_DT
mechanism_NN
of_IN
HIV-1_NN
activation_NN
with_IN
heat_NN
shock_NN
has_VBZ
not_RB
been_VBN
fully_RB
elucidated_VBN
yet_RB
,_,
it_PRP
is_VBZ
presumed_VBN
PKC_NN
plays_VBZ
an_DT
important_JJ
role_NN
in_IN
HIV-1_NN
activation_NN
._.

Thus_RB
,_,
the_DT
present_JJ
observations_NNS
will_MD
provide_VB
a_DT
further_JJ
insight_NN
into_IN
the_DT
pathogenesis_NN
of_IN
HIV-1_NN
infections_NNS
._.

